FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer
FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer Fierce Pharma
411 материалов по теме, собраны автоматически из проверенных источников
FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer Fierce Pharma
BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Investing News Network
84-летний мужчина неожиданно обнаружил у себя рак груди. Vietnam.vn
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Yahoo! Finance Canada
AstraZeneca Secures US FDA Approval for ETCAMAH Combination in Advanced Breast Cancer BioPharma APAC
MicroRNA-218 in breast cancer: protective ally or hidden driver? Bioengineer.org
Breast Cancer Treatment Sequencing 2026: Powerful New Insights for Better Outcomes Oncodaily
Predicting pathology response in triple-negative breast cancer using tumor-infiltrating lymphocytes Bioengineer.org
FDA approves Guardant360 CDx for ESR1 mutation testing in breast cancer MedTech World
AstraZeneca breast cancer drug wins US approval after trial cuts progression risk by 56% Indian Pharma Post
Affordable, quality breast cancer treatment available in Bangladesh daily-sun.com
Affordable, quality breast cancer treatment available in Bangladesh Bangladesh Sangbad Sangstha (BSS)
Болеют не только женщины: важные вопросы про рак груди у жителей Архангельской области 29.ru
FDA Approves New Breast Cancer Treatment That Targets Resistance Before Cancer Progresses Health and Me
ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer BioSpace